APOL1 Mediated Kidney Disease: What Does the Future Hold?
APOL1 Mediated Kidney Disease: What Does the Future Hold? is organized by National Kidney Foundation (NKF).
Available From: 6/27/2023
Available Until: 6/27/2024
Course Description:
APOL1-mediated kidney disease (AMKD) is a kidney disorder caused by certain apolipoprotein L1 (APOL1) genetic mutations. This genetic disease can lead to renal cell injury and damage to the glomeruli, resulting in proteinuria and progression to end stage kidney disease. This program will address APOL1 epidemiology and potential mechanisms of AMKD, as well as implications of genetic ancestry and approaches to testing, followed by a discussion of current and emerging therapies for AMKD.
Learning Objectives:
• Discuss the discovery, epidemiology, and potential mechanisms of APOL1
• Identify the implications of genetic ancestry and strategies for APOL1 testing
• Evaluate current and emerging therapeutic options for APOL1-mediated kidney disease
Additional details will be posted as soon as information is available.